[go: up one dir, main page]

GB201512206D0 - Site-specific antibody-drug conjugates - Google Patents

Site-specific antibody-drug conjugates

Info

Publication number
GB201512206D0
GB201512206D0 GBGB1512206.2A GB201512206A GB201512206D0 GB 201512206 D0 GB201512206 D0 GB 201512206D0 GB 201512206 A GB201512206 A GB 201512206A GB 201512206 D0 GB201512206 D0 GB 201512206D0
Authority
GB
United Kingdom
Prior art keywords
site
specific antibody
drug conjugates
conjugates
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1512206.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Cancer Research Technology Ltd
Original Assignee
BERKEL PATRICIUS H C VAN AND CANCER RES TECHNOLOGY Ltd
BERKEL PATRICIUS H C VAN AND CANCER RESEARCH TECHNOLOGY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERKEL PATRICIUS H C VAN AND CANCER RES TECHNOLOGY Ltd, BERKEL PATRICIUS H C VAN AND CANCER RESEARCH TECHNOLOGY Ltd filed Critical BERKEL PATRICIUS H C VAN AND CANCER RES TECHNOLOGY Ltd
Priority to GBGB1512206.2A priority Critical patent/GB201512206D0/en
Publication of GB201512206D0 publication Critical patent/GB201512206D0/en
Ceased legal-status Critical Current

Links

GBGB1512206.2A 2015-07-13 2015-07-13 Site-specific antibody-drug conjugates Ceased GB201512206D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1512206.2A GB201512206D0 (en) 2015-07-13 2015-07-13 Site-specific antibody-drug conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1512206.2A GB201512206D0 (en) 2015-07-13 2015-07-13 Site-specific antibody-drug conjugates

Publications (1)

Publication Number Publication Date
GB201512206D0 true GB201512206D0 (en) 2015-08-19

Family

ID=54013853

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1512206.2A Ceased GB201512206D0 (en) 2015-07-13 2015-07-13 Site-specific antibody-drug conjugates

Country Status (1)

Country Link
GB (1) GB201512206D0 (en)

Similar Documents

Publication Publication Date Title
GB201506402D0 (en) Site-specific antibody-drug conjugates
GB201506407D0 (en) Site-specific antibody-drug conjugates
GB201506393D0 (en) Site-specific antibody-drug conjugates
GB201506405D0 (en) Site-specific antibody-drug conjugates
GB201506399D0 (en) Site-specific antibody-drug conjugates
ZA201607385B (en) Anti-ptk7 antibody-drug conjugates
PL3579883T3 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201506389D0 (en) Site-specific antibody-drug conjugates
ZA201700306B (en) Her2 antibody-drug conjugates
PL3544636T3 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201506388D0 (en) Site-specific antibody-drug conjugates
GB201702031D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201506394D0 (en) Site-specific antibody-drug conjugates
LT3895736T (en) Antibody-drug conjugates targeting uparap
GB201512205D0 (en) Site-specific antibody-drug conjugates
GB201512206D0 (en) Site-specific antibody-drug conjugates
GB201512199D0 (en) Site-specific antibody-drug conjugates
GB201512201D0 (en) Site-specific antibody-drug conjugates
GB201512214D0 (en) Site-specific antibody-drug conjugates
GB201512213D0 (en) Site-specific antibody-drug conjugates
GB201512209D0 (en) Site-Specific Antibody-Drug Conjugates
GB201512208D0 (en) Site-specific antibody-drug conjugates
GB201406729D0 (en) Site-specific antibody-drug conjugates
GB201406727D0 (en) Site-specific antibody-drug conjugates
GB201406728D0 (en) Site-specific antibody-drug conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
COOA Change in applicant's name or ownership of the application

Owner name: MEDIMMUNE LIMITED

Free format text: FORMER OWNERS: VAN PATRICIUS HENRIKUS CORNELIS BERKEL;CANCER RESEARCH TECHNOLOGY LIMITED

Owner name: ADC THERAPEUTICS S.A.

Free format text: FORMER OWNERS: VAN PATRICIUS HENRIKUS CORNELIS BERKEL;CANCER RESEARCH TECHNOLOGY LIMITED

Owner name: CANCER RESEARCH TECHNOLOGY LIMITED

Free format text: FORMER OWNERS: VAN PATRICIUS HENRIKUS CORNELIS BERKEL;CANCER RESEARCH TECHNOLOGY LIMITED